GW&K Investment Management LLC Decreases Position in Integer Holdings Co. (NYSE:ITGR)

GW&K Investment Management LLC trimmed its stake in Integer Holdings Co. (NYSE:ITGR - Free Report) by 17.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 433,531 shares of the medical equipment provider's stock after selling 88,600 shares during the period. GW&K Investment Management LLC owned approximately 1.29% of Integer worth $57,452,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Geode Capital Management LLC boosted its stake in Integer by 1.2% in the third quarter. Geode Capital Management LLC now owns 764,528 shares of the medical equipment provider's stock valued at $99,408,000 after acquiring an additional 9,421 shares in the last quarter. Loomis Sayles & Co. L P grew its stake in Integer by 3.0% during the 3rd quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider's stock worth $69,943,000 after buying an additional 15,446 shares during the last quarter. Congress Asset Management Co. increased its position in Integer by 2.0% during the fourth quarter. Congress Asset Management Co. now owns 498,350 shares of the medical equipment provider's stock worth $66,041,000 after buying an additional 9,565 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in Integer by 1.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 404,029 shares of the medical equipment provider's stock valued at $52,524,000 after buying an additional 4,946 shares during the last quarter. Finally, Lord Abbett & CO. LLC boosted its holdings in shares of Integer by 3.5% in the third quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider's stock valued at $37,716,000 after acquiring an additional 9,754 shares during the period. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Price Performance

Shares of ITGR traded down $1.67 during mid-day trading on Tuesday, hitting $118.54. The company's stock had a trading volume of 514,840 shares, compared to its average volume of 280,264. The firm has a 50-day simple moving average of $136.57 and a 200 day simple moving average of $133.04. Integer Holdings Co. has a 1-year low of $107.11 and a 1-year high of $146.36. The firm has a market capitalization of $3.99 billion, a P/E ratio of 35.28, a P/E/G ratio of 1.72 and a beta of 1.13. The company has a current ratio of 2.95, a quick ratio of 2.09 and a debt-to-equity ratio of 0.62.

Integer (NYSE:ITGR - Get Free Report) last issued its earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 EPS for the quarter, missing the consensus estimate of $1.46 by ($0.03). The company had revenue of $449.50 million for the quarter, compared to analysts' expectations of $446.28 million. Integer had a return on equity of 11.65% and a net margin of 6.92%. Analysts predict that Integer Holdings Co. will post 6.01 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on ITGR. Oppenheimer cut shares of Integer from an "outperform" rating to a "market perform" rating in a report on Friday, February 21st. Truist Financial upped their target price on shares of Integer from $147.00 to $163.00 and gave the company a "buy" rating in a report on Wednesday, December 11th. Citigroup increased their target price on shares of Integer from $130.00 to $145.00 and gave the stock a "neutral" rating in a research note on Wednesday, December 11th. KeyCorp boosted their price target on Integer from $144.00 to $154.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Finally, Benchmark increased their price objective on Integer from $140.00 to $150.00 and gave the stock a "buy" rating in a research report on Friday, February 21st. Two equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, Integer has an average rating of "Moderate Buy" and a consensus target price of $147.67.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.